Skip to main content

Table 2 Characteristics of the patients with haemolysis

From: Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India

Patient ID

Age in years/gender

Baseline parasitemia (parasites/µl)

Haemoglobin g/dl

LDH levels (IU/L)

Reticulocyte %

Total dose of intravenous artesunate (mg/kg)

Blood transfusion for hemolysis

Possible reason for haemolysis

2

7/F

63,485

Base line: 11.9

Day 7: 12.1

Minimum Hb: 10.4

Day 7: 694

Highest level (Day 14): 951

Day 7: 0.6

Highest level (Day 14): 3.8

14

None

Post artesunate delayed haemolysis

9

13/M

143

Base line 7.6

Day 7: − 8.9

Minimum Hb: 6

Day 7: 1021

Highest level (Day 21): 1161

Day 7: 0.3

Highest level (Day 28): 0.5

14

None

Renal involvement

12

2.4/M

2496

Base line 13.1

Day 7: − 11.5

Minimum Hb: 7.1

Day 7: 839

Highest level (Day 21): 1300

Day 7: 0.3

Highest level (Day 28): 5.7

14

Day-21

Post artesunate delayed haemolysis

17

13/M

394

Base line: 12.4

Day 7: 10.1

Minimum Hb: 6.7

Day 7: 985

Highest level (Day 28):1575

Day 7: 1.6

Highest level (Day 28): 8.2

12

None

Intravenous ceftriaxone

21

2/M

8748

Base line: 6.7

Day 7: 8.8

Minimum Hb: 7.6

Day 7: 302

Highest level (Day 14): 642

Day 7: 2.1

Highest level (Day 14): 3.3

15

None

Post artesunate delayed haemolysis